89 related articles for article (PubMed ID: 7532325)
1. Flow and antibody binding properties of hydrated fibrins prepared from plasma, platelet rich plasma and whole blood.
Bini A; Callender S; Procyk R; Blombäck B; Kudryk BJ
Thromb Res; 1994 Oct; 76(2):145-56. PubMed ID: 7532325
[TBL] [Abstract][Full Text] [Related]
2. Accessibility of epitopes on fibrin clots and fibrinogen gels.
Procyk R; Kudryk B; Callender S; Blombäck B
Blood; 1991 Apr; 77(7):1469-75. PubMed ID: 1706954
[TBL] [Abstract][Full Text] [Related]
3. Monoclonal antibodies to human fibrin: interaction with other animal fibrins.
Edgell T; McEvoy F; Webbon P; Gaffney PJ
Thromb Haemost; 1996 Apr; 75(4):595-9. PubMed ID: 8743185
[TBL] [Abstract][Full Text] [Related]
4. Availability of the B beta(15-21) epitope on cross-linked human fibrin and its plasmic degradation products.
Chen F; Haber E; Matsueda GR
Thromb Haemost; 1992 Mar; 67(3):335-40. PubMed ID: 1379385
[TBL] [Abstract][Full Text] [Related]
5. Characterization of a monoclonal antibody specific to the amino terminus of the alpha-chain of human fibrin.
Mao SJ; Rechtin AE; Krstenansky JL; Jackson RL
Thromb Haemost; 1990 Jun; 63(3):445-8. PubMed ID: 2402748
[TBL] [Abstract][Full Text] [Related]
6. A monoclonal antibody that recognizes a neo-antigen exposed in the E domain of fibrin monomer complexed with fibrinogen or its derivatives: its application to the measurement of soluble fibrin in plasma.
Soe G; Kohno I; Inuzuka K; Itoh Y; Matsuda M
Blood; 1996 Sep; 88(6):2109-17. PubMed ID: 8822930
[TBL] [Abstract][Full Text] [Related]
7. Binding properties of monoclonal antibodies against human fragment D-dimer of cross-linked fibrin to human plasma clots in an in vivo model in rabbits.
Holvoet P; Stassen JM; Hashimoto Y; Spriggs D; Devos P; Collen D
Thromb Haemost; 1989 Apr; 61(2):307-13. PubMed ID: 2749602
[TBL] [Abstract][Full Text] [Related]
8. Binding of a new monoclonal antibody against N-terminal heptapeptide of fibrin alpha-chain to fibrin polymerization site 'A': effects of fibrinogen and fibrinogen derivatives, and pretreatment of samples with NaSCN.
Dempfle CE; Dollman M; Lill H; Puzzovio D; Dessauer A; Heene DL
Blood Coagul Fibrinolysis; 1993 Feb; 4(1):79-86. PubMed ID: 8457657
[TBL] [Abstract][Full Text] [Related]
9. Fibrin detected in plasma of patients with disseminated intravascular coagulation by fibrin-specific antibodies consists primarily of high molecular weight factor XIIIa-crosslinked and plasmin-modified complexes partially containing fibrinopeptide A.
Pfitzner SA; Dempfle CE; Matsuda M; Heene DL
Thromb Haemost; 1997 Sep; 78(3):1069-78. PubMed ID: 9308756
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of monoclonal antifibrin antibodies by their binding to human blood clots.
Liau CS; Haber E; Matsueda GR
Thromb Haemost; 1987 Feb; 57(1):49-54. PubMed ID: 3590080
[TBL] [Abstract][Full Text] [Related]
11. Monoclonal antibody designated T2G1 reacts with human fibrin beta-chain but not with the corresponding chain from mouse fibrin.
Kudryk BJ; Bini A
Arterioscler Thromb Vasc Biol; 2000 Jul; 20(7):1848-9. PubMed ID: 10894828
[No Abstract] [Full Text] [Related]
12. A novel monoclonal antibody to fibrin monomer and soluble fibrin for the detection of soluble fibrin in plasma.
Hamano A; Tanaka S; Takeda Y; Umeda M; Sakata Y
Clin Chim Acta; 2002 Apr; 318(1-2):25-32. PubMed ID: 11880109
[TBL] [Abstract][Full Text] [Related]
13. A neoantigenic determinant in the D-dimer fragment of fibrin.
Lugovskoy EV; Kolesnikova IN; Gritsenko PG; Zolotareva EN; Gaffney P; Nieuwenhuizen W; Komisarenko SV
Thromb Res; 2002 Aug; 107(3-4):151-6. PubMed ID: 12431482
[TBL] [Abstract][Full Text] [Related]
14. The monoclonal antibody that recognizes an epitope in the C-terminal region of the fibrinogen alpha-chain reacts with soluble fibrin and fibrin monomer generated by thrombin but not with those formed as plasmin degradation products.
Suzuki A; Ebinuma H; Matsuo M; Miyazaki O; Yago H
Thromb Res; 2007; 121(3):377-85. PubMed ID: 17561232
[TBL] [Abstract][Full Text] [Related]
15. Generation and partial characterization of five monoclonal antibodies with high affinities for fibrin.
Tymkewycz PM; Creighton Kempsford LJ; Gaffney PJ
Blood Coagul Fibrinolysis; 1993 Apr; 4(2):211-21. PubMed ID: 7684615
[TBL] [Abstract][Full Text] [Related]
16. Interaction of histidine-rich glycoprotein with fibrinogen and fibrin.
Leung LL
J Clin Invest; 1986 Apr; 77(4):1305-11. PubMed ID: 3958188
[TBL] [Abstract][Full Text] [Related]
17. Monoclonal antibody to human cross-linked fibrin.
Houranieh A; Statland BE; Davis GL; Ito RK; Relias V; Kudryk B; Yunis EJ
Hybridoma; 1988 Feb; 7(1):55-68. PubMed ID: 2453448
[TBL] [Abstract][Full Text] [Related]
18. Binding properties on Sepharose insolubilized fibrinogen and fibrin, of various species of fibrinogen and fibrin solubilized in plasma.
Nilsen DW; Holm B; Brosstad F
Thromb Res; 1986 May; 42(4):449-59. PubMed ID: 3715811
[TBL] [Abstract][Full Text] [Related]
19. Discrimination between fibrin and fibrinogen by a monoclonal antibody against a synthetic peptide.
Scheefers-Borchel U; Müller-Berghaus G; Fuhge P; Eberle R; Heimburger N
Proc Natl Acad Sci U S A; 1985 Oct; 82(20):7091-5. PubMed ID: 2413458
[TBL] [Abstract][Full Text] [Related]
20. Characterisation of the chains of human fibrinogen isolated by perfusion chromatography using fibrin specific monoclonal antibodies.
Raut S; Corran PH; Gaffney PJ
Thromb Res; 1995 Aug; 79(4):405-13. PubMed ID: 7482444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
